CVS Health Reaffirms FY22 Outlook

Ahead of its meetings with investors later in June, CVS Health (CVS) on Thursday reaffirmed its earnings and adjusted earnings guidance for the full-year 2022.

For fiscal 2022, the company continues to project earnings in the range of $6.93 to $7.13 per share and adjusted earnings in the range of $8.20 to $8.40 per share.

The company had in early December 2021 projected total revenues for the full-year 2022 to be between $304.0 billion and $309.0 billion.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $8.36 per share on revenues of $308.88 billion for the year. Analysts' estimates typically exclude special items.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Luxury electric car maker Tesla Inc. has produced more than 3 million vehicles, of which 1 million in Shanghai Gigafactory, according to its founder and Chief Executive Officer Elon Musk. In a tweet on Sunday, Musk said, "Congrats Giga Shanghai on making millionth car! Total Teslas made now over 3M." King's Hawaiian is recalling its Pretzel Slider Buns, Pretzel Hamburger Buns and Pretzel Bites products as they contain one ingredient already recalled by Lyons Magnus, the U.S. Food And Drug Administration said. The Pretzel recall was initiated out of an abundance of caution after one of its supplier Lyons Magnus recently called back various nutritional and beverage products. German consumer goods maker Henkel AG & Co. reported Monday weak profit in its first half amid increasing costs, despite growth in sales. Further, the company maintained its adjusted earnings forecast for fiscal 2022, but raised outlook for organic sales growth.For fiscal 2022, the company continues to expect adjusted earnings per preferred share to decline in the range of 15 percent to 35 percent
Follow RTT